The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient

Sponsor
Dr Cipto Mangunkusumo General Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05370248
Collaborator
(none)
44
1
2
12
3.7

Study Details

Study Description

Brief Summary

This is a randomized clinical trial to measure the effect of tidal volume (group 6 ml/kg vs 10 ml/kg) on diaphragm dysfunction on mechanically ventilated critical patient.

Condition or Disease Intervention/Treatment Phase
  • Other: Tidal volume 6 ml/kg
  • Other: Tidal volume 10 ml/kg
N/A

Detailed Description

Patient was enrolled in the first day receiving mechanical ventilation in ICU. Patient was included to group A or group B. Group A patient will receive tidal volume of 6 ml/kg and group B patient will receive tidal volume of 10 ml/kg. The assignment was randomized. Followed for 3 days. After 24, 48, and 72 hours, patient blood will be collected to measure the interleukin value, and diaphragm dysfunction will be observed by the use of ultrasonography by expert doctor from radiology department. Data will be analyzed statistically if there is an effect of tidal volume difference on diaphragm dysfunction and interleukin-6 as marker of inflammation. The minimal sample of patient is 44 patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patient was divided into group A and B. Group A received tidal volume of 6 ml/kg and group B received tidal volume of 10 ml/kg.Patient was divided into group A and B. Group A received tidal volume of 6 ml/kg and group B received tidal volume of 10 ml/kg.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Participants are blinded to which group they belong and they have given consent to that. The person assigning patients to each group is the research assistant. The person setting the mechanical ventilator is the anesthesiology resident. The person assessing outcome with ultrasound is radiology department staff, who does not know which group the patient belong. The person assessing outcome of interleukin is laboratory personnel, who does not know which group the patient belong. The person collecting and freezing data into worksheet is the research assistant. The person analyzing final data is the primary investigator.
Primary Purpose:
Other
Official Title:
The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient: a Randomized Clinical Trial
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: The six

The group who received tidal volume of 6 ml/kg from mechanical ventilation

Other: Tidal volume 6 ml/kg
Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.

Active Comparator: The ten

The group who received tidal volume of 10 ml/kg from mechanical ventilation

Other: Tidal volume 10 ml/kg
Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.

Outcome Measures

Primary Outcome Measures

  1. DD-24 [24 hours after mechanical ventilation]

    Diaphragm dysfunction 24 hours after mechanical ventilation assessed by ultrasound.

  2. DD-48 [48 hours after mechanical ventilation]

    Diaphragm dysfunction 48 hours after mechanical ventilation assessed by ultrasound.

  3. DD-72 [72 hours after mechanical ventilation]

    Diaphragm dysfunction 72 hours after mechanical ventilation assessed by ultrasound.

Secondary Outcome Measures

  1. IL-6-24 [24 hours after mechanical ventilation]

    Blook interleukin 6 24 hours after mechanical ventilation

  2. IL-6-48 [48 hours after mechanical ventilation]

    Blook interleukin 6 48 hours after mechanical ventilation

  3. IL-6-72 [72 hours after mechanical ventilation]

    Blook interleukin 6 72 hours after mechanical ventilation

Other Outcome Measures

  1. Discharge outcome [Up to three months after mechanical ventilation]

    The outcome at hospital discharge (alive or death)

  2. LOS in hospital [Up to three months after mechanical ventilation]

    Length of stay (days) in hospital

  3. LOS in ICU [Up to three months after mechanical ventilation]

    Length of stay (days) in ICU

  4. Weaning failure [Up to three months after mechanical ventilation]

    The condition where patient failed for spontaneous breathing trial after mechanical ventilation. Grouped into success/failed.

  5. Intubation time [At extubation after mechanical ventilation]

    Time (hours) long when a patient was intubated

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Minimum age 18 years old

  • Critically ill patients

Exclusion Criteria:
  • Patient with ARDS (PaO2/FiO2 <200)

  • Pregnant woman

  • Patient with history of cardiac or thorax surgery 14 days prior to admission

  • Patient with severe peripheral musculoskeletal conditions

  • Patient with prolonged in-hospital stay (>2 weeks) in the last 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dr Cipto Mangunkusumo Hospital Jakarta Pusat DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Dr Cipto Mangunkusumo General Hospital

Investigators

  • Study Chair: Dita Aditianingsih, Dr, Dr Cipto Mangunkusumo Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Darma Putra Sitepu, Anesthesiologist Consultant In-Training, Principal Investigator, Dr Cipto Mangunkusumo General Hospital
ClinicalTrials.gov Identifier:
NCT05370248
Other Study ID Numbers:
  • DPS1
First Posted:
May 11, 2022
Last Update Posted:
May 11, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Darma Putra Sitepu, Anesthesiologist Consultant In-Training, Principal Investigator, Dr Cipto Mangunkusumo General Hospital

Study Results

No Results Posted as of May 11, 2022